Vanda Pharmaceuticals (VNDA) Q3 2025 Earnings

Jul 31Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.57
-0.41
-0.24
-0.08

Details

Expected EPS
-0.356667
Actual EPS
-0.46
Surprise EPS
-0.1
Surprise Percent
-28.97%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VNDA⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts